Promising Pneumonia Vaccine Under Development

Share this content:
Promising Pneumonia Vaccine Under Development
Promising Pneumonia Vaccine Under Development

WEDNESDAY, Nov. 1, 2017 (HealthDay News) -- A pneumonia vaccine under development provides the "most comprehensive coverage" to date and alleviates antimicrobial concerns, according to a study published online Oct. 18 in Science Advances.

Charles H. Jones, from Abcombi Biosciences Inc., in Buffalo, New York, and colleagues designed a comprehensive pneumonia vaccine and tested it in animal models.

The researchers report that non-covalent colocalization of two classes of complementary antigens, one to prevent the colonization of the most aggressive S. pneumoniae serotypes and another to restrict virulence transition, provides complete vaccine effectiveness in animal subjects and the most comprehensive coverage of disease reported to date. Tests performed in mice and rabbits showed the new vaccine stimulated an immune response to 72 of the more than 90 known strains of S. pneumoniae.

"As a result, the proposed vaccine formulation offers universal pneumococcal disease prevention with the prospect of effectively managing a disease that afflicts tens to hundreds of millions globally," write the authors.

Two study authors are drafting a provisional patent application related to this work, and two are co-founders of Abcombi Biosciences, which focuses on vaccine design.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

Medicaid Expansion Ups Preemptive Listing for Kidney Transplant

Medicaid Expansion Ups Preemptive Listing for Kidney Transplant

From pre- to post-expansion period, 59 percent relative increase in Medicaid-covered preemptive listings

BCG Vaccine Tied to Reduced Hyperglycemia in Type 1 Diabetes

BCG Vaccine Tied to Reduced Hyperglycemia in Type ...

Systemic shift in glucose metabolism from oxidative phosphorylation to aerobic glycolysis

Many Physicians Not Prepared for End-of-Life Talks With Patients

Many Physicians Not Prepared for End-of-Life Talks With ...

Additional training, reimbursement may foster these critical conversations, authors say

is free, fast, and customized just for you!




Already a member?

Sign In Now »